Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2009-10-21
pubmed:abstractText
Introduction of lipoamino acid (LAA), Lys-palmitoyl, and cationization into a series of galanin analogues yielded systemically active anticonvulsant compounds. To study the relationship between the LAA structure and anticonvulsant activity, orthogonally protected LAAs were synthesized in which the Lys side chain was coupled to fatty acids varying in length from C(8) to C(18) or was coupled to a monodispersed polyethylene glycol, PEG(4). Galanin receptor affinity, serum stability, lipophilicity (log D), and activity in the 6 Hz mouse model of epilepsy of each of the newly synthesized analogues were determined following systemic administration. The presence of various LAAs or Lys(MPEG(4)) did not affect the receptor binding properties of the modified peptides, but their anticonvulsant activities varied substantially and were generally correlated with their lipophilicity. Our results suggest that varying the length or polarity of the LAA residue adjacent to positively charged amino acid residues may effectively modulate the antiepileptic activity of the galanin analogues.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-10088996, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-10395447, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-10508449, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-10794683, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-10812941, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-11033091, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-11502512, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-11712539, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-11786210, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-11882009, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-12368071, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-12617941, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-12682214, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-12783857, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-14980646, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-15166257, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-15359587, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-15567469, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-15717056, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-15721174, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-15745807, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-15783069, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-16075406, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-16699066, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-16753826, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-16882457, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-16979183, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-17181137, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-18221832, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-18335425, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-18500639, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-19053761, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-1975697, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-2413968, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-7812692, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-8371162, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-8574648, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-8941392, http://linkedlifedata.com/resource/pubmed/commentcorrection/19199479-8996222
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1520-4804
pubmed:author
pubmed:issnType
Electronic
pubmed:day
12
pubmed:volume
52
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1310-6
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:19199479-Amino Acid Sequence, pubmed-meshheading:19199479-Animals, pubmed-meshheading:19199479-Anticonvulsants, pubmed-meshheading:19199479-Binding, Competitive, pubmed-meshheading:19199479-Chemistry, Physical, pubmed-meshheading:19199479-Circular Dichroism, pubmed-meshheading:19199479-Epilepsy, pubmed-meshheading:19199479-Fatty Acids, pubmed-meshheading:19199479-Galanin, pubmed-meshheading:19199479-Humans, pubmed-meshheading:19199479-Hydrophobic and Hydrophilic Interactions, pubmed-meshheading:19199479-Lysine, pubmed-meshheading:19199479-Mice, pubmed-meshheading:19199479-Molecular Sequence Data, pubmed-meshheading:19199479-Protein Structure, Secondary, pubmed-meshheading:19199479-Rats, pubmed-meshheading:19199479-Receptor, Galanin, Type 1, pubmed-meshheading:19199479-Receptor, Galanin, Type 2, pubmed-meshheading:19199479-Structure-Activity Relationship
pubmed:year
2009
pubmed:articleTitle
Structural requirements for a lipoamino acid in modulating the anticonvulsant activities of systemically active galanin analogues.
More...